Minocycline Hydrochloride Patent Expiration
Minocycline Hydrochloride was first introduced by Triax Pharmaceuticals Llc
Minocycline Hydrochloride Patents
Given below is the list of patents protecting Minocycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Emrosi | US10905664 | Methods for treating inflammatory skin conditions | Jan 07, 2039 | Journey |
Emrosi | US11191740 | Methods for treating inflammatory skin conditions | Jan 07, 2039 | Journey |
Emrosi | US11364212 | Methods for treating inflammatory skin conditions | Jan 07, 2039 | Journey |
Amzeeq | US10398641 | Compositions and methods for treating rosacea and acne | Sep 08, 2037 | Journey |
Amzeeq | US10849847 | Compositions and methods for treating rosacea and acne | Sep 08, 2037 | Journey |
Minolira | US11103517 | Pharmaceutical compositions for minocycline | Apr 07, 2036 | Epi Hlth |
Minocin | US11944634 | Tetracycline compositions | Oct 16, 2032 | Rempex |
Solodyn | US9192615 | Method for the treatment of acne and certain dosage forms thereof | Nov 17, 2031 | Bausch |
Minocin | US12161656 | Tetracycline compositions | May 12, 2031 | Rempex |
Minocin | US9084802 | Tetracycline compositions | May 12, 2031 | Rempex |
Minocin | US9278105 | Tetracycline compositions | May 12, 2031 | Rempex |
Amzeeq | US10086080 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Amzeeq | US10137200 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
Amzeeq | US10213512 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Amzeeq | US10265404 | Compositions, gels and foams with rheology modulators and uses thereof | Oct 01, 2030 | Journey |
Amzeeq | US10517882 | Method for healing of an infected acne lesion without scarring | Oct 01, 2030 | Journey |
Amzeeq | US10821187 | Compositions, gels and foams with rheology modulators and uses thereof | Oct 01, 2030 | Journey |
Amzeeq | US8865139 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Amzeeq | US8945516 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
Amzeeq | US8992896 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Amzeeq | US9675700 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Zilxi | US10213512 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Zilxi | US10265404 | Compositions, gels and foams with rheology modulators and uses thereof | Oct 01, 2030 | Journey |
Zilxi | US10322186 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Zilxi | US10946101 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
Zilxi | US12138311 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Zilxi | US8865139 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Zilxi | US8945516 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
Zilxi | US8992896 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Zilxi | US9675700 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
Solodyn | US7541347 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Bausch |
Solodyn | US7544373 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Bausch |
Ximino | US7541347 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Journey |
Ximino | US7544373 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Journey |
Solodyn | US7919483 | Method for the treatment of acne | Mar 07, 2027 | Bausch |
Ximino | US7919483 | Method for the treatment of acne | Mar 07, 2027 | Journey |
Solodyn | US7790705 | Minocycline oral dosage forms for the treatment of acne |
Jun 24, 2025
(Expired) | Bausch |
Solodyn | US8252776 | Minocycline oral dosage forms for the treatment of acne |
Jun 24, 2025
(Expired) | Bausch |
Solodyn | US8268804 | Minocycline oral dosage forms for the treatment of acne |
Jun 24, 2025
(Expired) | Bausch |
Solodyn | US8722650 | Extended-release minocycline dosage forms |
Jun 24, 2025
(Expired) | Bausch |
Ximino | US7790705 | Minocycline oral dosage forms for the treatment of acne |
Jun 24, 2025
(Expired) | Journey |
Ximino | US8252776 | Minocycline oral dosage forms for the treatment of acne |
Jun 24, 2025
(Expired) | Journey |
Ximino | US8268804 | Minocycline oral dosage forms for the treatment of acne |
Jun 24, 2025
(Expired) | Journey |
Arestin | US6682348 | Dispensing apparatus and cartridge |
Mar 29, 2022
(Expired) | Orapharma |
Arestin | US7699609 | Dispensing apparatus and cartridge with deformable tip |
Mar 29, 2022
(Expired) | Orapharma |
Solodyn | US5908838 | Method for the treatment of acne |
Feb 19, 2018
(Expired) | Bausch |
Ximino | US5908838 | Method for the treatment of acne |
Feb 19, 2018
(Expired) | Journey |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Minocycline Hydrochloride's patents.
Latest Legal Activities on Minocycline Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Minocycline Hydrochloride.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 12th Year, Large Entity | 20 Feb, 2024 | US8268804(Litigated) |
Payment of Maintenance Fee, 12th Year, Large Entity | 23 Jan, 2024 | US8252776(Litigated) |
Payment of Maintenance Fee, 8th Year, Large Entity | 20 Apr, 2023 | US9192615 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Dec, 2022 | US10322186 |
Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2022 | US7919483(Litigated) |
Payment of Maintenance Fee, 12th Year, Large Entity | 23 Feb, 2022 | US7790705(Litigated) |
Recordation of Patent Grant Mailed Critical
| 16 Mar, 2021 | US10946101 |
Patent Issue Date Used in PTA Calculation Critical
| 16 Mar, 2021 | US10946101 |
Email Notification Critical
| 26 Feb, 2021 | US10946101 |
Issue Notification Mailed Critical
| 24 Feb, 2021 | US10946101 |
Minocycline Hydrochloride's Family Patents
